BSTG — Biostage Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapNeutral
- $75.22m
- $76.34m
Annual cashflow statement for Biostage, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.9 | -7.53 | -8.33 | -4.87 | -7.98 |
| Depreciation | |||||
| Non-Cash Items | 1.19 | 0.844 | 1.69 | 1.13 | 0.557 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.701 | -1.21 | 0.373 | -0.488 | 4.69 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -11 | -7.64 | -6.06 | -4.04 | -2.63 |
| Capital Expenditures | -0.136 | -0.131 | -0.129 | -0.007 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.064 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.136 | -0.067 | -0.129 | -0.007 | 0 |
| Financing Cash Flow Items | 0.3 | -0.3 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.2 | 5.02 | 5.8 | 4.16 | 2.84 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.1 | -2.68 | -0.392 | 0.113 | 0.216 |